Our study revealed that B-MYB mRNA is stabilized by ENO1 in breast cancer and then initiates PDK1 transcription and ultimately activates the AKT (T308)/mTOR (S2448) signaling pathway. This evidence concerns the gene MYBL2 and breast carcinoma.